Products

AstroIPO

Uncover key insights about Identixweb IPO key details, timelines, Lot size, SWOT analysis, Key financial metrics and expert detailed review.

astroipo.in Finance / Financial Data & Research

AI Benchmark
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Unknown
No monthly subscription pricing
Creators
Mihir Gohel
No social account linked
Launched
21mo ago
2025-02-11 · Est.

Traffic

Monthly visitsData through Oct 2026

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Your trusted partner for ipo success

    Feb 11, 2025 · 21mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

  • Direct41%
  • Organic Search30%
  • Referrals9%
  • Social6%
  • Other15%

Countries

  • India76%
  • United States24%

Search

Domain authority —Domain registered 2024-03-29

KeywordMonthly volume
ipo gmp368.6K
ipo gmp live25.7K
live ipo gmp21.9K
gmp live10.5K
gmo ipo6,740

Traffic data: Vaneform

Pricing

Pricing page not identified yet, or no public pricing listed.

Pages & changes

Tracked since 2025-02-11

Key pages

Weekly snapshots

No page snapshots yet. Once followed, home and pricing pages are captured weekly.

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does AstroIPO get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is AstroIPO and what platforms does it support?
AstroIPO is catalogued under Financial Data & Research: Uncover key insights about Identixweb IPO key details, timelines, Lot size, SWOT analysis, Key financial metrics and expert detailed review.. Supported platforms: Web.

Related products in this category

Finance / Financial Data & Research

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.